Women scientists claim Nobel prize for defying ageing

The discovery of a biological gatekeeper that prevents genetic code from fraying with age has won three American scientists this year’s Nobel prize for medicine.

The award — and the R9-million prize money — is shared by Elizabeth Blackburn (60), Carol Greider (48) and Jack Szostak (56).
It is the first time the foundation has honoured two women at once. The medicine prize has been awarded to 10 women since it was established in 1901.

The researchers identified one of the most critical processes in living organisms, with deep implications for understanding ageing, cancers and inherited diseases.

Blackburn, a University of California biochemist, made headlines once before when she was fired from former president George W Bush’s council on bioethics for criticising his opposition to stem cell research.

Greider, a geneticist at Johns Hopkins University in Baltimore, was Blackburn’s student when the two made their discovery. Szostak was born in London and grew up in Canada, joining the Harvard Medical School in 1979.

Their experiments solved one of the great mysteries of biology, showing how cells copy their chromosomes when they divide.
The first breakthrough came when Blackburn was studying chromosomes in a pond-dwelling organism called tetrahymena. She noticed that at the end of each of the creature’s chromosomes was a repeating DNA sequence, spelt out by the letters CCCCAA.

Her work caught the eye of Szostak, who had developed ‘mini-chromosomes” from DNA strands and was investigating what happened when he injected them into yeast cells. Each time the cells divided, the mini-chromosomes degraded, until they vanished.

The two joined forces to make mini-chromosomes with the CCCCAA sequences at either end. When these were injected into yeast, the DNA sequence protected the chromosomes when they were copied. The researchers called the genetic caps “telomeres”, meaning “end part”.

In 1984 Greider discovered telomerase, the enzyme that makes telomeres. Further studies revealed that healthy telomeres delay ageing in cells, prompting research into potential anti-ageing treatments. —

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever. But it comes at a cost. Advertisers are cancelling campaigns, and our live events have come to an abrupt halt. Our income has been slashed.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years. We’ve survived thanks to the support of our readers, we will need you to help us get through this.

To help us ensure another 35 future years of fiercely independent journalism, please subscribe.

Advertisting

Nehawu launches urgent court bid over protective gear for health...

The health workers’ union says the government has rebuffed its attempts to meet about mitigating risks to workers

Stay at home, Cyril said. But what about the homeless?

In Tshwane, forcing homeless people off the street resulted in chaos and the abuse of a vulnerable population. In Durban, a smooth, well-planned operation fared far better

Press Releases

New energy mix on the cards

REI4P already has and will continue to yield thousands of employment opportunities

The online value of executive education in a Covid-19 world

Executive education courses further develop the skills of leaders in the workplace

Sisa Ntshona urges everyone to stay home, and consider travelling later

Sisa Ntshona has urged everyone to limit their movements in line with government’s request

SAB Zenzele’s special AGM postponed until further notice

An arrangement has been announced for shareholders and retailers to receive a 77.5% cash payout

20th Edition of the National Teaching Awards

Teachers are seldom recognised but they are indispensable to the country's education system

Awards affirm the vital work that teachers do

Government is committed to empowering South Africa’s teachers with skills, knowledge and techniques for a changing world

SAB Zenzele special AGM rescheduled to March 25 2020

New voting arrangements are being made to safeguard the health of shareholders